Trial Profile
A randomized, open-label, multiple doses, crossover study to evaluate a pharmacokinetic drug interaction and safety of Candesartan free combination of Candesartan and Amlodipine and Candesartan monotherapy in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Amlodipine
- Indications Cardiovascular disorders; Heart failure; Hypertension
- Focus Pharmacokinetics
- Acronyms CKD-330(C)
- Sponsors Chong Kun Dang
- 02 Sep 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 09 May 2014 New trial record